4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-006271
Options or other derivatives
- General Counsel/Secretary acquired 699,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Leavitt Chase C. General Counsel/Secretary | 2021-03-15 | Grant or award · Employee Stock Option (Right to Buy) | +699,100 | 699,100 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…